DEB-TACE: Current standards in drug-eluting therapy for liver malignancies
Drug-eluting bead transarterial chemoembolization (DEB-TACE) is a relatively new treatment method that uses drug-eluting microbeads to target tumours. It is essential for interventional radiologists to learn the indications, patient selection, procedural techniques, and the associated pros and cons of DEB-TACE treatment. Despite its well-known and proven clinical indication and efficacy, significant debate still persists regarding the most effective use of DEB-TACE, including its comparative efficacy to other techniques (cTACE, bland embolization), optimal embolic particle sizes, tumour staging considerations, potential complications, and overall therapeutic advantages. This webinar will provide participants with a thorough understanding of how to safely and effectively perform DEB-TACE for treating HCC and mCRC, along with insights into its evolving role in the future. During the case discussions, attendees will learn tips and tricks so that they can avoid potential complications and improve the treatment’s clinical value. Attendees will also have the opportunity to ask questions and engage in dynamic, interactive discussions based on real-world clinical experiences.
Learning objectives
- To learn how to perform safe and effective DEB-TACE by real case examples.
- To understand patient selection on DEB-TACE for HCC and colorectal metastases.
- To understand the role of DEB-TACE in the current landscape of liver-directed locoregional therapies.
Programme
Introduction by the moderators
Roberto Iezzi (Rome/IT) and Thomas Kröncke (Augsburg/DE)
Role of DEB-TACE in HCC
Tobias Jakobs (Munich/DE)
Role of DEB TACE in mCRC
Geert Maleux (Leuven/BE)
Future of DEB TACE
TBD
Discussion and Q&A
Take-home points by the moderators
Roberto Iezzi (Rome/IT) and Thomas Kröncke (Augsburg/DE)
Faculty
Moderators
Roberto Iezzi
Moderator
(Rome/IT)
Thomas Kröncke
Moderator
(Augsburg/DE)
Speakers
Tobias Jakobs (Munich/DE)
Geert Maleux (Leuven/BE)
Join free of charge!
Access to this webinar is available free of charge to all interested parties. All you need is your CIRSE login details. Don’t have a CIRSE account yet? Not to worry! It only takes two minutes to set up a new account which will enable you to register.